Medicine and Dentistry
Endoscopic Ultrasound
69%
Neoplasm
67%
Pancreas Cancer
57%
Stomach Cancer
52%
Helicobacter Pylori
44%
Endoscopy
43%
Narrow Band Imaging
42%
Malignant Neoplasm
37%
Hepatocellular Carcinoma
35%
Gastrointestinal Stromal Tumor
35%
Echography
29%
Pancreas Adenocarcinoma
27%
Pylorus
27%
Endoscopic Ultrasound Guided Fine Needle Biopsy
26%
Bevacizumab
26%
Fine-Needle Aspiration
25%
Cancer
24%
Diagnosis
24%
Biliary Tract Drainage
22%
Cholangiocarcinoma
21%
Pancreas Tumor
21%
Endoscopic Submucosal Dissection
20%
Atezolizumab
20%
Overall Survival
19%
Chronic Pancreatitis
18%
Disease
16%
Ulcerative Colitis
16%
Crohn's Disease
16%
Ras Signaling
16%
Differential Diagnosis
16%
Pancreas Disease
16%
Adenoma
15%
Stenosis
15%
Colorectal Cancer
15%
Confocal Laser Scanning Microscopy
14%
Ulcer
14%
Stomach Mucosa
14%
White Light Endoscopy
14%
Autoimmune Pancreatitis
14%
Choledochoduodenostomy
13%
Multivariate Analysis
13%
Intraductal Papillary Mucinous Tumor
13%
Immunoglobulin G4
13%
Methylation
13%
Observational Study
13%
Upper Digestive Tract
13%
microRNA
13%
Helicobacter Infection
13%
Lymphatic Follicle
13%
Macrogol
13%
Adoptive Immunotherapy
13%
Zoledronic Acid
13%
Killer Cell
13%
Computer Assisted Tomography
12%
Eradication Therapy
11%
Arm
11%
Chronic Kidney Disease
11%
Morphology
10%
Adverse Event
10%
Mucosa
10%
Biological Marker
10%
Magnifying Endoscopy
10%
CpG Island
10%
Meta-Analysis
10%
Polyp
9%
Pancreatitis
9%
Lymphocyte
9%
Hazard Ratio
9%
Fluorouracil
9%
Lymph Node Metastasis
9%
First-Line Chemotherapy
9%
Cholestasis
8%
Cohort Analysis
8%
Liver Function
8%
Clinical Trial
8%
Bile Duct
8%
Odds Ratio
8%
Steroid Treatment
8%
Median Survival Time
8%
Transcatheter Arterial Chemoembolization
8%
Image Enhanced Endoscopy
8%
Surgery
8%
Colorectal Tumor
8%
Promoter Region
8%
Pancreatic Duct
8%
Vermiform Appendix
8%
Colonoscopy
8%
Clinical Study
7%
Meta-Regression
7%
Combination Therapy
7%
Oncology
7%
Venous Ulcer
7%
Tyrosine-Kinase Inhibitor
7%
Contrast-Enhanced Ultrasound
7%
Obstructive Jaundice
7%
Diagnostic Accuracy
7%
Duodenum
7%
Lymphadenopathy
7%
Steroid Therapy
7%
Stomach Ulcer
7%
Pharmacology, Toxicology and Pharmaceutical Science
Stomach Cancer
100%
Liver Cell Carcinoma
72%
Chemotherapy
64%
Bevacizumab
60%
Atezolizumab
46%
Overall Survival
35%
Pancreas Cancer
35%
Adverse Event
32%
Neoplasm
28%
Progression Free Survival
27%
Sunitinib
26%
Disease
24%
Malignant Neoplasm
24%
Helicobacter Pylori
24%
Clinical Trial
24%
Capecitabine
21%
Imatinib
20%
Gastrointestinal Stromal Tumor
20%
Immunotherapy
20%
Cisplatin
19%
Colorectal Cancer
17%
Irinotecan
16%
Metastatic Colorectal Cancer
16%
Combination Therapy
15%
Helicobacter Infection
14%
Paclitaxel
14%
Fluoropyrimidine
13%
Atrophic Gastritis
13%
Colorectal Tumor
13%
Duodenum Ulcer
13%
Observational Study
13%
Ramucirumab
13%
Precancer
13%
microRNA
13%
Zoledronic Acid
13%
Pancreas Islet Cell Tumor
13%
Placebo
13%
Adenoma
12%
Metaplasia
12%
Alpha Fetoprotein
12%
Lenvatinib
12%
Ulcer
11%
Neutropenia
11%
Biological Marker
11%
Pancreas Adenocarcinoma
10%
Sorafenib
9%
Fluorouracil
9%
Oxaliplatin
9%
Colorectal Adenoma
8%
Stomach Ulcer
8%
Taxane
8%
Docetaxel
8%
Gamma Urogastrone
8%
microRNA 31
7%
Bleeding
7%
Monotherapy
7%
Crohn's Disease
7%
Trastuzumab
7%
End Stage Liver Disease
7%
Diseases
7%
Solid Malignant Neoplasm
6%
Prevalence
6%
Jejunum Ulcer
6%
Intestine Metaplasia
6%
Comorbidity
6%
Sclerosing Cholangitis
6%
Omeprazole
6%
Tremelimumab
6%
Immunoglobulin G4
6%
Ethanol
6%
Small Interfering RNA
6%
Regorafenib
6%
Colon Polyposis
6%
Liver Metastasis
6%
Vascular Disease
6%
Oncolytic Herpes Virus
6%
Xenobiotic Agent
6%
Cetuximab
6%
Anticoagulation Therapy
6%
Motesanib
6%
Gastrointestinal Hemorrhage
6%
Cabozantinib
6%
Neuroendocrine Tumor
6%
Folinic Acid
6%
Tumor Necrosis Factor
6%
Heat Shock Protein 70
6%
Hypovitaminosis D
6%
UFT
6%
Intestine Tumor
6%
Liver Disease
6%
Remission
6%
Diabetes Mellitus
6%
Second-Line Chemotherapy
6%
Hepatitis B Virus
6%
Chronic Hepatitis B
6%
Adjuvant
6%
Antacid Agent
6%
microRNA 124
6%
Vasculotropin
6%
Nilotinib
6%
Keyphrases
Atezolizumab Plus Bevacizumab
33%
Advanced Hepatocellular Carcinoma
27%
Gastric Cancer
21%
Advanced Gastric Cancer
20%
Pre-microRNA
20%
Chemotherapy
16%
Steroid Treatment
14%
Gastrointestinal Stromal Tumor
13%
Ulcerative Colitis
13%
Pancreatic Neuroendocrine Tumors (pNETs)
13%
Clinical Outcomes
13%
REG4
13%
Endoscopic Ultrasound-guided Biliary Drainage (EUS-BD)
13%
Endoscopic Ultrasound-guided Choledochoduodenostomy
13%
Common Genetic Variants
13%
IgG4-related Sclerosing Cholangitis
13%
Combination Therapy
13%
Rs3746444
13%
Lenvatinib
12%
Gastric Cancer Patients
11%
Periampullary Cancer
10%
Adverse Events
10%
Rs11614913
10%
Docetaxel
10%
MiR-146a rs2910164
10%
Cancer Risk
10%
Liver Function
8%
Endoscopic Ultrasound-guided
8%
Tumor
8%
Abdominal Ultrasonography
8%
Biliary Tract Carcinoma
8%
Odds Ratio
7%
Lymph Node Metastasis
7%
Clinical Practice
7%
Pancreatic Cancer
7%
Hepatocellular Carcinoma
7%
Complete Response
7%
Differential Diagnosis
7%
Gene Polymorphism
7%
IgG4-positive
7%
Endoscopic Ultrasonography
7%
Overall Survival
7%
Single nucleotide Polymorphism
6%
Endoscopic Ultrasound
6%
Helicobacter Pylori Eradication
6%
Interleukin-17 (IL-17)
6%
Solid Pseudopapillary Tumor
6%
Endoscopic Features
6%
Ramucirumab
6%
Magnifying Endoscopy with Narrow-band Imaging
6%
Abdominal Lymphadenopathy
6%
Gastrointestinal Submucosal Tumor
6%
Preoperative Diagnosis
6%
Second-look Endoscopy
6%
Transabdominal
6%
Two-step Method
6%
Confocal Laser Endomicroscopy
6%
Peutz-Jeghers Polyp
6%
Survey in Japan
6%
Nationwide Survey
6%
CapeOX
6%
New FP
6%
Cape
6%
Ulcerative Colitis-associated Neoplasia
6%
Tremelimumab
6%
Endoscopic Staging
6%
Leukocyte DNA
6%
IGF2 DMR
6%
Protease-activated Receptor 2 (PAR2)
6%
STI571
6%
Imatinib Failure
6%
Food Taste
6%
Diagnostic Biomarker
6%
Individual Response
6%
Response to Food
6%
Metastatic Pancreatic Cancer
6%
Palliative Biliary Drainage
6%
EUS-guided Choledochoduodenostomy
6%
Endoscopic Pancreatic Stent
6%
Feasibility Trial
6%
Anti-oncomir
6%
Gene Aberrations
6%
Plummer-Vinson Syndrome
6%
Esophageal Web
6%
Iron Therapy
6%
MIF Gene
6%
Pancreatology
6%
IL-1 Polymorphism
6%
International Association
6%
TNF Polymorphism
6%
Epigenome Evolution
6%
Performance Status 2
6%
Stomach Cancer
6%
Randomized Prospective Trial
6%
Prior Exposure
6%
Motesanib
6%
Submucosal Hematoma
6%
Clinical Impact
6%
Distal Colon
6%
R0 Resection
6%